First patients test new oral drug for Tough-to-Treat blood cancers

NCT ID NCT05753501

Ongoing Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

Summary

This is the first human study of an experimental oral drug called ABBV-101 for people with advanced B-cell blood cancers that have returned or not responded to previous treatments. The main goals are to find a safe dose and see how the body processes the drug, while also checking for early signs that it might help control the cancer. The study will enroll adults with various types of non-Hodgkin lymphoma who have few or no other treatment options left.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

A.O.U. CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO - Ospedale Molinette /ID# 253530

Turin, Piedmont, 10126, Italy
ASST Grande Ospedale Metropolitano Niguarda /ID# 253532

Milan, Milano, 20162, Italy
ASST Papa Giovanni XXIII /ID# 260317

Bergamo, 24127, Italy
Addenbrookes Hospital /ID# 256242

Cambridge, Cambridgeshire, CB2 2QQ, United Kingdom
Arizona Oncology Associates, PC-HOPE /ID# 252351

Tempe, Arizona, 85284-1812, United States
Beth Israel Deaconess Medical Center /ID# 249302

Boston, Massachusetts, 02215-5400, United States
CHRU Lille - Hopital Claude Huriez /ID# 253665

Lille, Nord, 59037, France
CHU Montpellier - Hopital Saint Eloi /ID# 253666

Montpellier, Herault, 34295, France
CHUM Notre-Dame Hospital /ID# 253428

Montreal, Quebec, H2L 4M1, Canada
Centre Hospitalier Universitaire de Nantes, Hotel Dieu -HME /ID# 256248

Nantes, Pays de la Loire Region, 44000, France
Charite Universitaetsklinikum Berlin - Campus Benjamin Franklin /ID# 257431

Berlin, 12203, Germany
Hadassah Medical Center-Hebrew University /ID# 251123

Jerusalem, Jerusalem, 91120, Israel
Hopital Saint-Louis /ID# 253663

Paris, 75010, France
Hospital Universitario Fundacion Jimenez Diaz /ID# 253654

Madrid, 28040, Spain
Hospital Universitario HM Sanchinarro /ID# 253655

Madrid, 28050, Spain
Hospital Universitario Puerta de Hierro - Majadahonda /ID# 260196

Majadahonda, Madrid, 28222, Spain
Hospital Universitario Ramon y Cajal /ID# 260450

Madrid, 28034, Spain
Hospital Universitario Vall de Hebron /ID# 260447

Barcelona, 08035, Spain
Hospital Universitario de Salamanca /ID# 253656

Salamanca, 37711, Spain
IRCCS AOU di Bologna Policlinico Sant Orsola Malpighi /ID# 255172

Bologna, 40138, Italy
IRCCS Ospedale San Raffaele /ID# 253531

Milan, Milano, 20132, Italy
Institut Bergonie /ID# 253664

Bordeaux, Gironde, 33000, France
Institut Gustave Roussy /ID# 253662

Villejuif, Val-de-Marne, 94805, France
Kings College Hospital NHS Foundation Trust /ID# 253670

London, Greater London, SE5 9RS, United Kingdom
Kyoto University Hospital /ID# 261837

Kyoto, Kyoto, 606-8507, Japan
Leicester Royal Infirmary /ID# 255171

Leicester, England, LE1 5WW, United Kingdom
MD Anderson Cancer Center /ID# 249293

Houston, Texas, 77030, United States
National Cancer Center Hospital /ID# 250680

Chuo-ku, Tokyo, 104-0045, Japan
National Cancer Center Hospital East /ID# 250684

Kashiwa-shi, Chiba, 277-8577, Japan
New York Oncology Hematology - Albany Cancer Center /ID# 252240

Albany, New York, 12206-5013, United States
Northwell Health - Monter Cancer Center /ID# 250422

Lake Success, New York, 11042, United States
Northwestern University Feinberg School of Medicine /ID# 249347

Chicago, Illinois, 60611-2927, United States
Oncology Assoc. of Oregon PC - WVCI and Research Ctr - Springfield /ID# 249309

Eugene, Oregon, 97401-6036, United States
Rocky Mountain Cancer Centers - Lone Tree /ID# 252237

Lone Tree, Colorado, 80124, United States
Rutgers Cancer Institute of New Jersey /ID# 249323

New Brunswick, New Jersey, 08901, United States
Stanford University /ID# 249683

Palo Alto, California, 94304, United States
Tel Aviv Sourasky Medical Center /ID# 259608

Tel Aviv, Tel Aviv, 6423906, Israel
The Cancer Institute Hospital Of JFCR /ID# 260375

Koto-ku, Tokyo, 135-8550, Japan
The Chaim Sheba Medical Center /ID# 251122

Ramat Gan, Tel Aviv, 5265601, Israel
UC Health - Cincinnati /ID# 249299

Cincinnati, Ohio, 45267-2800, United States
UC Irvine Medical Center /ID# 263020

Orange, California, 92868-3201, United States
Universitaetsklinikum Hamburg-Eppendorf /ID# 264566

Hamburg, 20246, Germany
Universitaetsklinikum Ulm /ID# 253742

Ulm, Baden-Wurttemberg, 89081, Germany
Universitaetsklinikum Wuerzburg /ID# 254636

Würzburg, Bavaria, 97080, Germany
Universitaetsklinikum des Saarlandes /ID# 257435

Homburg, Saarland, 66424, Germany
Universitaetsmedizin Rostock /ID# 259657

Rostock, Mecklenburg-Vorpommern, 18057, Germany
University College London Hospital /ID# 260202

London, Greater London, NW1 2BU, United Kingdom
University Health Network_Princess Margaret Cancer Centre /ID# 253483

Toronto, Ontario, M5G 2M9, Canada
University of Pennsylvania /ID# 250341

Philadelphia, Pennsylvania, 19104, United States
University of Rochester Medical Center /ID# 249324

Rochester, New York, 14642-0001, United States
Yitzhak Shamir Medical Center /ID# 254566

Ẕerifin, Central District, 70300, Israel

Conditions

Explore the condition pages connected to this study.

HEMATOLOGIC CANCER